Mulligan Richard
Insider CIK 1376247 · SANA Head of SanaX, Director · IFF Director · ENZN Director · BIIB Director · BHC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SANA Sana Biotechnology, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| IFF INTERNATIONAL FLAVORS & FR | M Exercise deriv | 2026-05-01 | 2026-05-04 | 1,712 | $70.81 | $121.2K | 0 | SEC↗ |
| IFF INTERNATIONAL FLAVORS & FR | M Exercise | 2026-05-01 | 2026-05-04 | 1,712 | — | $0 | 1,712 | SEC↗ |
| IFF INTERNATIONAL FLAVORS & FR | A Award deriv | 2026-04-29 | 2026-04-30 | 2,903 | — | $0 | 2,903 | SEC↗ |
| IFF INTERNATIONAL FLAVORS & FR | A Award deriv | 2025-11-03 | 2025-11-04 | 1,712 | — | $0 | 1,712 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 80,000 | — | $0 | 80,000 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2025-05-16 | 2025-05-20 | 54,347 | — | $0 | 155,616 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2024-09-25 | 2024-09-26 | 150,000 | $3.89 | $583.5K | 2,698,121 | SEC↗ |
| SANA Sana Biotechnology, Inc. | S Sale | 2024-09-24 | 2024-09-26 | 150,000 | $4.08 | $612.0K | 2,848,121 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2024-06-06 | 2024-07-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2024-06-06 | 2024-06-07 | 54,278 | — | $0 | 54,278 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2024-05-17 | 2024-05-20 | 35,360 | — | $0 | 101,269 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2023-05-19 | 2023-05-19 | 29,205 | — | $0 | 65,909 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2023-03-02 | 2023-03-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2022-06-24 | 2022-06-28 | 34,387 | — | $0 | 36,704 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2022-06-15 | 2022-06-17 | 1,370 | — | $0 | 15,099 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2022-05-13 | 2022-05-17 | 2,317 | — | $0 | 2,317 | SEC↗ |
| SANA Sana Biotechnology, Inc. | A Award deriv | 2022-03-03 | 2022-03-08 | 250,000 | — | $0 | 250,000 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2021-07-01 | 2021-07-02 | 775 | — | $0 | 13,729 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2020-06-03 | 2020-06-05 | 890 | — | $0 | 12,954 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2019-06-19 | 2019-06-20 | 1,155 | — | $0 | 12,064 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2018-06-12 | 2018-06-14 | 880 | — | $0 | 10,909 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2017-06-07 | 2017-06-09 | 1,055 | — | $0 | 10,029 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2016-06-08 | 2016-06-09 | 1,060 | — | $0 | 8,950 | SEC↗ |
| BIIB BIOGEN INC. | A Award | 2015-06-10 | 2015-06-11 | 695 | — | $0 | 7,890 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award | 2014-06-12 | 2014-06-16 | 870 | — | $0 | 7,195 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award | 2013-06-12 | 2013-06-13 | 1,305 | — | $0 | 6,325 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-05-29 | 2013-05-31 | 3,000 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-05-29 | 2013-05-31 | 3,000 | $53.43 | $160.3K | 5,020 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-05-28 | 2013-05-29 | 2,975 | — | $0 | 3,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-05-28 | 2013-05-29 | 35,000 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 300 | $237.51 | $71.3K | 4,695 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 900 | $238.11 | $214.3K | 36,120 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-05-28 | 2013-05-29 | 35,000 | $53.43 | $1.87M | 37,020 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 700 | $239.74 | $167.8K | 2,020 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 1,975 | $239.30 | $472.6K | 2,720 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 8,497 | $239.71 | $2.04M | 27,623 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-05-28 | 2013-05-29 | 2,975 | $53.43 | $159.0K | 4,995 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 4,694 | $242.27 | $1.14M | 2,020 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 10,006 | $241.70 | $2.42M | 6,714 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-05-28 | 2013-05-29 | 10,903 | $240.45 | $2.62M | 16,720 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-03-22 | 2013-03-25 | 2,900 | $176.88 | $513.0K | 2,020 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-03-13 | 2013-03-13 | 5,000 | $175.75 | $878.8K | 4,920 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-03-13 | 2013-03-13 | 2,980 | $174.75 | $520.8K | 9,920 | SEC↗ |
| ENZN ENZON PHARMACEUTICALS INC | A Award deriv | 2013-01-02 | 2013-01-04 | 35,226 | — | $0 | 35,226 | SEC↗ |
| ENZN ENZON PHARMACEUTICALS INC | A Award | 2012-07-02 | 2012-07-03 | 18,670 | — | $0 | 49,064 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award | 2012-06-08 | 2012-06-11 | 2,020 | — | $0 | 12,900 | SEC↗ |
| ENZN ENZON PHARMACEUTICALS INC | A Award deriv | 2012-01-03 | 2012-01-05 | 19,240 | — | $0 | 19,240 | SEC↗ |